Web Analytics

3 Latest Announced Rounds

  • $12,000,000
    Unknown

    3 Investors

    Hospital & Health Care
    Jun 4th, 2025
  • Undisclosed Amount
    Series A

    4 Investors

    Biotechnology Research
    Jun 4th, 2025
  • $21,000,000
    Unknown
    Software Development
    Jun 4th, 2025
$745.90M Raised in 51 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Bicara Therapeutics

start up
United States - Cambridge, Massachusetts
  • 07/03/2023
  • Series B
  • $108,000,000

Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.


Related People

Claire MazumdarFounder

Claire Mazumdar United States - Boston, Massachusetts

N/A